Article Details

AstraZeneca to acquire Alexion, enhancing presence in immunology

Retrieved on: 2020-12-14 15:45:00

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca to acquire Alexion, enhancing presence in immunology. View article details on hiswai:

Excerpt

... an anti-complement component 5 (C5) <b>monoclonal antibody</b>. ... half-life and hence the availability of pathogenic immunoglobulin G (IgG) antibodies.

Article found on: www.biopharma-reporter.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up